Position in LQDA
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$5,092,753
+$1,380,760 QoQ
Shares Held
63,875
-35.1% QoQ
Ownership
0.071%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#83
of 334 holders
Holding Since
Mar 2020
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LQDA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026VICTORY CAPITAL MANAGEMENT INC holds $597,918,972 across 29 Drug Manufacturers - Specialty & Generic names. LQDA ranks #15 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
2,122,749 | $152,540,743 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
618,499 | $104,241,821 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,575,098 | $53,364,320 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
470,051 | $52,147,457 | |
| 5 | ALKS |
Alkermes plc.
|
916,709 | $48,035,551 | |
| 6 | VTRS |
Viatris Inc
|
2,683,275 | $42,610,407 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
504,853 | $32,285,348 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
760,252 | $27,521,122 |
All Filings in LQDA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,092,753 | 63,875 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $3,711,993 | 98,357 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $275,368 | 7,984 | Shares | Sole | 2026-02-13 | |
| 2020-03-31 | $7,371 | 1,565 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||